Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
CALYPSO: Final Results of Savolitinib and Durvalumab Combination in Metastatic Papillary Renal Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 20, 2026
Oncology drug development in the UK: analysis of the past 25 years and focus on the 2026 reboot of the clinical trial regulatory framework.
Journal: British journal of cancer
Published: January 16, 2026
Phase II Study Investigating the Safety and Efficacy of Savolitinib and Durvalumab in Metastatic Papillary Renal Cancer (CALYPSO).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 22, 2023
Effect of the COVID-19 pandemic on cancer treatment and research.
Journal: The Lancet. Haematology
Published: March 30, 2020
Showing 1-4 of 4
Last Updated: 09/26/2026